|
| | HB1004 Engrossed | | LRB099 04835 JLK 24864 b |
|
|
1 | | AN ACT concerning health.
|
2 | | Be it enacted by the People of the State of Illinois, |
3 | | represented in the General Assembly:
|
4 | | Section 5. The State Finance Act is amended by changing |
5 | | Section 5.666 as follows:
|
6 | | (30 ILCS 105/5.666)
|
7 | | (Section scheduled to be repealed on July 1, 2016) |
8 | | Sec. 5.666. The African-American HIV/AIDS Response Fund. |
9 | | This Section is repealed on July 1, 2026 2016 . |
10 | | (Source: P.A. 94-797, eff. 1-1-07; 95-331, eff. 8-21-07.)
|
11 | | Section 10. The African-American HIV/AIDS Response Act is |
12 | | amended by changing Section 27 as follows: |
13 | | (410 ILCS 303/27) |
14 | | (Section scheduled to be repealed on July 1, 2016) |
15 | | Sec. 27. African-American HIV/AIDS Response Fund. |
16 | | (a) The African-American HIV/AIDS Response Fund is created |
17 | | as a special fund in the State treasury. Moneys deposited into |
18 | | the Fund shall, subject to appropriation, be used for grants |
19 | | for programs to prevent the transmission of HIV and other |
20 | | programs and activities consistent with the purposes of this |
21 | | Act, including, but not limited to, preventing and treating |
|
| | HB1004 Engrossed | - 2 - | LRB099 04835 JLK 24864 b |
|
|
1 | | HIV/AIDS, the creation of an HIV/AIDS service delivery system, |
2 | | and the administration of the Act. Moneys for the Fund shall |
3 | | come from appropriations by the General Assembly, federal |
4 | | funds, and other public resources. |
5 | | (b) The Fund shall provide resources for communities in |
6 | | Illinois to create an HIV/AIDS service delivery system that |
7 | | reduces the disparity of HIV infection and AIDS cases between |
8 | | African-Americans and other population groups in Illinois that |
9 | | may be impacted by the disease by, including but, not limited |
10 | | to: |
11 | | (1) developing, implementing, and maintaining a |
12 | | comprehensive, culturally sensitive HIV Prevention Plan |
13 | | targeting communities that are identified as high-risk in |
14 | | terms of the impact of the disease on African-Americans; |
15 | | (2) developing, implementing, and maintaining a stable |
16 | | HIV/AIDS service delivery infrastructure in Illinois |
17 | | communities that will meet the needs of African-Americans; |
18 | | (3) developing, implementing, and maintaining a |
19 | | statewide HIV/AIDS testing program; |
20 | | (4) providing funding for HIV/AIDS social and |
21 | | scientific research to improve prevention and treatment; |
22 | | (5) providing comprehensive technical and other |
23 | | assistance to African-American community service |
24 | | organizations that are involved in HIV/AIDS prevention and |
25 | | treatment; |
26 | | (6) developing, implementing, and maintaining an |
|
| | HB1004 Engrossed | - 3 - | LRB099 04835 JLK 24864 b |
|
|
1 | | infrastructure for African-American community service |
2 | | organizations to make them less dependent on government |
3 | | resources; and |
4 | | (7) creating and maintaining at least 17 one-stop |
5 | | shopping HIV/AIDS facilities across the State. |
6 | | (c) When providing grants pursuant to this Fund, the |
7 | | Department of Public Health shall give priority to the |
8 | | development of comprehensive medical and social services to |
9 | | African-Americans at risk of infection from or infected with |
10 | | HIV/AIDS in areas of the State determined to have the greatest |
11 | | geographic prevalence of HIV/AIDS in the African-American |
12 | | population. |
13 | | (d) The Section is repealed on July 1, 2026 2016 .
|
14 | | (Source: P.A. 94-797, eff. 1-1-07.) |
15 | | Section 15. The AIDS Confidentiality Act is amended by |
16 | | changing Sections 3, 4, and 9 as follows:
|
17 | | (410 ILCS 305/3) (from Ch. 111 1/2, par. 7303)
|
18 | | Sec. 3. Definitions. When used in this Act:
|
19 | | (a) "AIDS" means acquired immunodeficiency syndrome. |
20 | | (b) "Authority" means the Illinois Health Information |
21 | | Exchange Authority established pursuant to the Illinois Health |
22 | | Information Exchange and Technology Act. |
23 | | (c) "Business associate" has the meaning ascribed to it |
24 | | under HIPAA, as specified in 45 CFR 160.103. |
|
| | HB1004 Engrossed | - 4 - | LRB099 04835 JLK 24864 b |
|
|
1 | | (d) "Covered entity" has the meaning ascribed to it under |
2 | | HIPAA, as specified in 45 CFR 160.103. |
3 | | (e) "De-identified information" means health information |
4 | | that is not individually identifiable as described under HIPAA, |
5 | | as specified in 45 CFR 164.514(b). |
6 | | (f) "Department" means the Illinois Department of Public |
7 | | Health or its designated agents.
|
8 | | (g) "Disclosure" has the meaning ascribed to it under |
9 | | HIPAA, as specified in 45 CFR 160.103. |
10 | | (h) "Health care operations" has the meaning ascribed to it |
11 | | under HIPAA, as specified in 45 CFR 164.501. |
12 | | (i) "Health care professional" means (i) a licensed |
13 | | physician, (ii) a
physician assistant
to whom the physician |
14 | | assistant's supervising physician has delegated the
provision |
15 | | of AIDS and
HIV-related health services, (iii) an advanced |
16 | | practice registered nurse who
has a written
collaborative |
17 | | agreement with a collaborating physician which authorizes the
|
18 | | provision of AIDS
and HIV-related health services, (iv) an |
19 | | advanced practice nurse or physician assistant who practices in |
20 | | a hospital or ambulatory surgical treatment center and |
21 | | possesses appropriate clinical privileges, (v) a licensed |
22 | | dentist, (vi) (v) a licensed podiatric physician, or (vii) (vi) |
23 | | an
individual certified to provide HIV testing and counseling |
24 | | by a state or local
public health
department. |
25 | | (j) "Health care provider" has the meaning ascribed to it |
26 | | under HIPAA, as specified in 45 CFR 160.103.
|
|
| | HB1004 Engrossed | - 5 - | LRB099 04835 JLK 24864 b |
|
|
1 | | (k) "Health facility" means a hospital, nursing home, blood |
2 | | bank, blood
center, sperm bank, or other health care |
3 | | institution, including any "health
facility" as that term is |
4 | | defined in the Illinois Finance Authority
Act.
|
5 | | (l) "Health information exchange" or "HIE" means a health |
6 | | information exchange or health information organization that |
7 | | oversees and governs the electronic exchange of health |
8 | | information that (i) is established pursuant to the Illinois |
9 | | Health Information Exchange and Technology Act, or any |
10 | | subsequent amendments thereto, and any administrative rules |
11 | | adopted thereunder; (ii) has established a data sharing |
12 | | arrangement with the Authority; or (iii) as of August 16, 2013, |
13 | | was designated by the Authority Board as a member of, or was |
14 | | represented on, the Authority Board's Regional Health |
15 | | Information Exchange Workgroup; provided that such designation
|
16 | | shall not require the establishment of a data sharing |
17 | | arrangement or other participation with the Illinois Health
|
18 | | Information Exchange or the payment of any fee. In certain |
19 | | circumstances, in accordance with HIPAA, an HIE will be a |
20 | | business associate. |
21 | | (m) "Health oversight agency" has the meaning ascribed to |
22 | | it under HIPAA, as specified in 45 CFR 164.501. |
23 | | (n) "HIPAA" means the Health Insurance Portability and |
24 | | Accountability Act of 1996, Public Law 104-191, as amended by |
25 | | the Health Information Technology for Economic and Clinical |
26 | | Health Act of 2009, Public Law 111-05, and any subsequent |
|
| | HB1004 Engrossed | - 6 - | LRB099 04835 JLK 24864 b |
|
|
1 | | amendments thereto and any regulations promulgated thereunder. |
2 | | (o) "HIV" means the human immunodeficiency virus. |
3 | | (p) "HIV-related information" means the identity of a |
4 | | person upon whom an HIV test is performed, the results of an |
5 | | HIV test, as well as diagnosis, treatment, and prescription |
6 | | information that reveals a patient is HIV-positive, including |
7 | | such information contained in a limited data set. "HIV-related |
8 | | information" does not include information that has been |
9 | | de-identified in accordance with HIPAA. |
10 | | (q) "Informed consent" means : |
11 | | (1) where a health care provider, health care |
12 | | professional, or health facility has implemented opt-in |
13 | | testing, a process by which an individual or their legal |
14 | | representative receives pre-test information, has an |
15 | | opportunity to ask questions, and consents verbally or in |
16 | | writing to the test without undue inducement or any element |
17 | | of force, fraud, deceit, duress, or other form of |
18 | | constraint or coercion; or |
19 | | (2) where a health care provider, health care |
20 | | professional, or health facility has implemented opt-out |
21 | | testing, the individual or their legal representative has |
22 | | been notified verbally or in writing that the test is |
23 | | planned, has received pre-test information, has been given |
24 | | the opportunity to ask questions and the opportunity to |
25 | | decline testing, and has not declined testing; where such |
26 | | notice is provided, consent for opt-out HIV testing may be |
|
| | HB1004 Engrossed | - 7 - | LRB099 04835 JLK 24864 b |
|
|
1 | | incorporated into the patient's general consent for |
2 | | medical care on the same basis as are other screening or |
3 | | diagnostic tests; a separate consent for opt-out HIV |
4 | | testing is not required. a written or verbal
agreement by |
5 | | the subject of a test or the subject's
legally authorized |
6 | | representative without undue inducement or any element
of |
7 | | force, fraud, deceit, duress, or other form of constraint |
8 | | or coercion,
which entails at least the following pre-test |
9 | | information: |
10 | | (1) a fair explanation of the test, including its |
11 | | purpose, potential
uses, limitations, and the meaning of |
12 | | its results; |
13 | | (2) a fair explanation of the procedures to be |
14 | | followed, including the
voluntary nature of the test, the |
15 | | right to withdraw consent to the testing
process at any |
16 | | time, the right to anonymity to the extent provided by law
|
17 | | with respect to participation in the test and disclosure of |
18 | | test results,
and the right to confidential treatment of
|
19 | | information identifying the subject of the test and the |
20 | | results of the
test, to the extent provided by law; and |
21 | | In addition, (3) where the person providing informed |
22 | | consent is a participant in an HIE, informed consent requires a |
23 | | fair explanation that the results of the patient's HIV test |
24 | | will be accessible through an HIE and meaningful disclosure of |
25 | | the patient's opt-out right under Section 9.6 of this Act. |
26 | | A health care provider, health care professional, or health |
|
| | HB1004 Engrossed | - 8 - | LRB099 04835 JLK 24864 b |
|
|
1 | | facility undertaking an informed consent process for HIV |
2 | | testing under this subsection may combine a form used to obtain |
3 | | informed consent for HIV testing with forms used to obtain |
4 | | written consent for general medical care or any other medical |
5 | | test or procedure, provided that the forms make it clear that |
6 | | the subject may consent to general medical care, tests, or |
7 | | procedures without being required to consent to HIV testing, |
8 | | and clearly explain how the subject may decline HIV testing. |
9 | | Health facility clerical staff or other staff responsible for |
10 | | the consent form for general medical care may obtain consent |
11 | | for HIV testing through a general consent form. |
12 | | Pre-test information may be provided in writing, verbally, |
13 | | or by video, electronic, or other means. The subject must be |
14 | | offered an opportunity to ask questions about the HIV test and |
15 | | decline testing. Nothing in this Act shall prohibit a health |
16 | | care provider or health care professional from combining a form |
17 | | used to obtain informed consent for HIV testing with forms used |
18 | | to obtain written consent for general medical care or any other |
19 | | medical test or procedure provided that the forms make it clear |
20 | | that the subject may consent to general medical care, tests, or |
21 | | medical procedures without being required to consent to HIV |
22 | | testing and clearly explain how the subject may opt out of HIV |
23 | | testing. |
24 | | (r) "Limited data set" has the meaning ascribed to it under |
25 | | HIPAA, as described in 45 CFR 164.514(e)(2). |
26 | | (s) "Minimum necessary" means the HIPAA standard for using, |
|
| | HB1004 Engrossed | - 9 - | LRB099 04835 JLK 24864 b |
|
|
1 | | disclosing, and requesting protected health information found |
2 | | in 45 CFR 164.502(b) and 164.514(d). |
3 | | (s-1) "Opt-in testing" means an approach where an HIV test |
4 | | is presented by offering the test and the patient accepts or |
5 | | declines testing. |
6 | | (s-3) "Opt-out testing" means an approach where an HIV test |
7 | | is presented such that a patient is notified that HIV testing |
8 | | may occur unless the patient declines. |
9 | | (t) "Organized health care arrangement" has the meaning |
10 | | ascribed to it under HIPAA, as specified in 45 CFR 160.103. |
11 | | (u) "Patient safety activities" has the meaning ascribed to |
12 | | it under 42 CFR 3.20. |
13 | | (v) "Payment" has the meaning ascribed to it under HIPAA, |
14 | | as specified in 45 CFR 164.501. |
15 | | (w) "Person" includes any natural person, partnership, |
16 | | association, joint venture, trust, governmental entity, public |
17 | | or private corporation, health facility, or other legal entity. |
18 | | (w-5) "Pre-test information" means: |
19 | | (1) a reasonable explanation of the test, including its |
20 | | purpose, potential uses, limitations, and the meaning of |
21 | | its results; and |
22 | | (2) a reasonable explanation of the procedures to be |
23 | | followed, including the voluntary nature of the test, the |
24 | | availability of a qualified person to answer questions, the |
25 | | right to withdraw consent to the testing process at any |
26 | | time, the right to anonymity to the extent provided by law |
|
| | HB1004 Engrossed | - 10 - | LRB099 04835 JLK 24864 b |
|
|
1 | | with respect to participation in the test and disclosure of |
2 | | test results, and the right to confidential treatment of |
3 | | information identifying the subject of the test and the |
4 | | results of the test, to the extent provided by law. |
5 | | Pre-test information may be provided in writing, verbally, |
6 | | or by video, electronic, or other means and may be provided as |
7 | | designated by the supervising health care professional or the |
8 | | health facility. |
9 | | For the purposes of this definition, a qualified person to |
10 | | answer questions is a health care professional or, when acting |
11 | | under the supervision of a health care professional, a |
12 | | registered nurse, medical assistant, or other person |
13 | | determined to be sufficiently knowledgeable about HIV testing, |
14 | | its purpose, potential uses, limitations, the meaning of the |
15 | | test results, and the testing procedures in the professional |
16 | | judgment of a supervising health care professional or as |
17 | | designated by a health care facility. |
18 | | (x) "Protected health information" has the meaning |
19 | | ascribed to it under HIPAA, as specified in 45 CFR 160.103. |
20 | | (y) "Research" has the meaning ascribed to it under HIPAA, |
21 | | as specified in 45 CFR 164.501. |
22 | | (z) "State agency" means an instrumentality of the State of |
23 | | Illinois and any instrumentality of another state that, |
24 | | pursuant to applicable law or a written undertaking with an |
25 | | instrumentality of the State of Illinois, is bound to protect |
26 | | the privacy of HIV-related information of Illinois persons.
|
|
| | HB1004 Engrossed | - 11 - | LRB099 04835 JLK 24864 b |
|
|
1 | | (aa) "Test" or "HIV test" means a test to determine the |
2 | | presence of the
antibody or antigen to HIV, or of HIV |
3 | | infection.
|
4 | | (bb) "Treatment" has the meaning ascribed to it under |
5 | | HIPAA, as specified in 45 CFR 164.501. |
6 | | (cc) "Use" has the meaning ascribed to it under HIPAA, as |
7 | | specified in 45 CFR 160.103, where context dictates.
|
8 | | (Source: P.A. 98-214, eff. 8-9-13; 98-1046, eff. 1-1-15 .)
|
9 | | (410 ILCS 305/4) (from Ch. 111 1/2, par. 7304)
|
10 | | Sec. 4. Informed consent. No person may order an HIV test |
11 | | without first providing pre-test information, as defined under |
12 | | subsection (w-5) of Section 3 of this Act, and receiving
the |
13 | | documented informed consent
of the subject of the test or the |
14 | | subject's legally authorized
representative in accordance with |
15 | | paragraph (1) or (2) of subsection (q) of Section 3 of this |
16 | | Act. |
17 | | A health care provider, health care professional, or health |
18 | | care facility conducting opt-in testing and obtaining informed |
19 | | consent pursuant to paragraph (1) of subsection (q) of Section |
20 | | 3 shall document verbal or written consent in the general |
21 | | consent for medical care, a separate consent form, or elsewhere |
22 | | in the medical record. |
23 | | A health care provider, health care professional, or health |
24 | | care facility conducting opt-out testing pursuant to paragraph |
25 | | (2) of subsection (q) of Section 3 shall document the subject's |
|
| | HB1004 Engrossed | - 12 - | LRB099 04835 JLK 24864 b |
|
|
1 | | or the subject's legally authorized representative's |
2 | | declination of the test in the medical record. Individual |
3 | | documentation of the provision of pre-test information to each |
4 | | test subject is not required. A health care provider, health |
5 | | care professional, or health facility conducting opt-out |
6 | | testing and shall establish and implement a written procedure |
7 | | for conducting opt-out testing pursuant to paragraph (2) of |
8 | | subsection (q) of Section 3 and for providing pre-test |
9 | | information, as that term is defined under subsection (w-5) of |
10 | | Section 3 of this Act . A health care facility or provider may |
11 | | offer opt-out HIV testing where the subject or the subject's |
12 | | legally authorized representative is informed that the subject |
13 | | will be tested for HIV unless he or she refuses. The health |
14 | | care facility or provider must document the provision of |
15 | | informed consent, including pre-test information, and whether |
16 | | the subject or the subject's legally authorized representative |
17 | | declined the offer of HIV testing.
|
18 | | (Source: P.A. 95-7, eff. 6-1-08 .)
|
19 | | (410 ILCS 305/9) (from Ch. 111 1/2, par. 7309)
|
20 | | Sec. 9. (1) No person may disclose or be compelled to |
21 | | disclose HIV-related information, except to the following |
22 | | persons:
|
23 | | (a) The subject of an HIV test or the subject's legally
|
24 | | authorized representative. A physician may notify the |
25 | | spouse or civil union partner of the
test subject, if the |
|
| | HB1004 Engrossed | - 13 - | LRB099 04835 JLK 24864 b |
|
|
1 | | test result is positive and has been confirmed
pursuant to |
2 | | rules adopted by the Department, provided that the |
3 | | physician has
first sought unsuccessfully to persuade the |
4 | | patient to notify the spouse or civil union partner or
|
5 | | that, a reasonable time after the patient has agreed to |
6 | | make the
notification, the physician has reason to believe |
7 | | that the patient has not
provided the notification. This |
8 | | paragraph shall not create a duty or
obligation under which |
9 | | a physician must notify the spouse or civil union partner |
10 | | of the test
results, nor shall such duty or obligation be |
11 | | implied. No civil liability
or criminal sanction under this |
12 | | Act shall be imposed for any disclosure or
non-disclosure |
13 | | of a test result to a spouse or civil union partner by a |
14 | | physician acting in good
faith under this paragraph. For |
15 | | the purpose of any proceedings, civil or
criminal, the good |
16 | | faith of any physician acting under this paragraph shall
be |
17 | | presumed.
|
18 | | (b) Any person designated in a legally effective |
19 | | authorization for release of the HIV-related information |
20 | | executed by the subject of the HIV-related information or |
21 | | the subject's legally
authorized representative.
|
22 | | (c) An authorized agent or employee of a health |
23 | | facility or health care
provider if the health facility or |
24 | | health care provider itself is
authorized to obtain the |
25 | | test results, the agent or employee provides
patient care |
26 | | or handles or processes specimens of body fluids or |
|
| | HB1004 Engrossed | - 14 - | LRB099 04835 JLK 24864 b |
|
|
1 | | tissues,
and the agent or employee has a need to know such |
2 | | information.
|
3 | | (d) The Department and local health authorities |
4 | | serving a population of over 1,000,000 residents or other |
5 | | local health authorities as designated by the Department, |
6 | | in accordance with rules for reporting, preventing, and
|
7 | | controlling the spread of disease and the conduct of public |
8 | | health surveillance, public health investigations, and |
9 | | public health interventions, as otherwise provided by |
10 | | State law.
The Department,
local health authorities, and |
11 | | authorized representatives shall not disclose HIV test |
12 | | results and HIV-related
information, publicly or in any |
13 | | action of any kind in any court or
before any tribunal, |
14 | | board, or agency. HIV test results and HIV-related |
15 | | information shall be
protected from disclosure in |
16 | | accordance with the provisions of Sections 8-2101
through |
17 | | 8-2105 of the Code of Civil Procedure.
|
18 | | (e) A health facility, health care provider, or health |
19 | | care professional which procures, processes,
distributes |
20 | | or uses: (i) a human body part from a deceased person
with |
21 | | respect to medical information regarding that person; or |
22 | | (ii) semen
provided prior to the effective date of this Act |
23 | | for the purpose of
artificial insemination.
|
24 | | (f) Health facility staff committees for the purposes |
25 | | of conducting
program monitoring, program evaluation or |
26 | | service reviews.
|
|
| | HB1004 Engrossed | - 15 - | LRB099 04835 JLK 24864 b |
|
|
1 | | (f-5) A court in accordance with the provisions of |
2 | | Section 12-5.01 of the Criminal Code of 2012. |
3 | | (g) (Blank).
|
4 | | (h) Any health care provider, health care |
5 | | professional, or employee of a health facility, and any
|
6 | | firefighter or EMR, EMT, A-EMT, paramedic, PHRN, or EMT-I, |
7 | | involved in an accidental direct
skin or mucous membrane |
8 | | contact with the blood or bodily fluids of an
individual |
9 | | which is of a nature that may transmit HIV, as determined |
10 | | by a
physician in his medical judgment.
|
11 | | (i) Any law enforcement officer, as defined in |
12 | | subsection (c) of
Section 7, involved in the line of duty |
13 | | in a direct skin or mucous membrane
contact with the blood |
14 | | or bodily fluids of an individual which is of a
nature that |
15 | | may transmit HIV, as determined by a physician in his |
16 | | medical
judgment.
|
17 | | (j) A temporary caretaker of a child taken into |
18 | | temporary protective
custody by the Department of Children |
19 | | and Family Services pursuant to Section 5
of the Abused and |
20 | | Neglected Child Reporting Act, as now or hereafter amended.
|
21 | | (k) In the case of a minor under 18 years of age whose |
22 | | test result is
positive and has been confirmed
pursuant to |
23 | | rules adopted by the Department, the health care |
24 | | professional who ordered the test shall make a reasonable
|
25 | | effort to notify the minor's parent or legal guardian if, |
26 | | in the
professional judgment
of the health care |
|
| | HB1004 Engrossed | - 16 - | LRB099 04835 JLK 24864 b |
|
|
1 | | professional, notification would be
in the best interest of |
2 | | the child and the health care professional has first
sought |
3 | | unsuccessfully to persuade the minor to notify the parent |
4 | | or legal
guardian or a reasonable time after the minor has |
5 | | agreed to notify
the parent or legal guardian, the health |
6 | | care professional has reason to
believe that the minor has |
7 | | not made the notification. This subsection
shall not create |
8 | | a duty or obligation under which a health care professional
|
9 | | must notify the minor's parent or legal guardian of the |
10 | | test results, nor
shall a duty or obligation be implied. No |
11 | | civil liability or criminal sanction
under this Act shall |
12 | | be imposed for any notification or non-notification of a
|
13 | | minor's test result by a health care professional acting in |
14 | | good faith under this
subsection. For the purpose of any |
15 | | proceeding, civil or criminal, the good
faith of any health |
16 | | care professional acting under this subsection shall be
|
17 | | presumed.
|
18 | | (2) All information and records held by a State agency, |
19 | | local health authority, or health oversight agency pertaining |
20 | | to HIV-related information shall be strictly confidential and |
21 | | exempt from copying and inspection under the Freedom of |
22 | | Information Act. The information and records shall not be |
23 | | released or made public by the State agency, local health |
24 | | authority, or health oversight agency, shall not be admissible |
25 | | as evidence nor discoverable in any action of any kind in any |
26 | | court or before any tribunal, board, agency, or person, and |
|
| | HB1004 Engrossed | - 17 - | LRB099 04835 JLK 24864 b |
|
|
1 | | shall be treated in the same manner as the information and |
2 | | those records subject to the provisions of Part 21 of Article |
3 | | VIII of the Code of Civil Procedure, except under the following |
4 | | circumstances: |
5 | | (A) when made with the written consent of all persons |
6 | | to whom the information pertains; or |
7 | | (B) when authorized by Section 5-4-3 of the Unified |
8 | | Code of Corrections. |
9 | | Disclosure shall be limited to those who have a need to |
10 | | know the information, and no additional disclosures may be |
11 | | made. |
12 | | (Source: P.A. 97-1046, eff. 8-21-12; 97-1150, eff. 1-25-13; |
13 | | 98-973, eff. 8-15-14; 98-1046, eff. 1-1-15; revised 10-1-14.)
|
14 | | (410 ILCS 305/5 rep.) |
15 | | Section 20. The AIDS Confidentiality Act is amended by |
16 | | repealing Section 5. |